Contributor:

David R. Chow, MD, interviewed by Timothy G. Murray, MD, MBA

COVID-19 Updates From Europe

Jordi Monés, MD, PhD; David H.W. Steel, MBBS, FRCOphth; Murat Oncel, MD; and Armin Wolf, MD, FEBO

COVID-19 Crisis: The Role of AAO and ASRS

John Kitchens, MD; David W. Parke II, MD; George Williams, MD; Timothy G. Murray, MD, MBA; and J. Michael Jumper, MD

Pneumatic Retinopexy

David Chow, MD

Ellex 2RT for Early AMD Intervention Roundtable

David Chow, MD, David Lubeck, MD, Frank Holz, MD, Netan Choudhry, MD, FRCS(C), Rishi P. Singh, MD, Robyn Guymer, AM, MBBS, PhD

Treatment Criteria for Ellex 2RT

David Lubeck, MD, David R. Chow, MD, Frank Holz, MD, Netan Choudhry, MD, FRCS(C), Rishi Singh, MD, Robyn Guymer, AM, MBBS, PhD

Identifying the Different Stages of AMD

David Lubeck, MD, David R. Chow, MD, Frank Holz, MD, Netan Choudhry, MD, FRCS(C), Rishi Singh, MD, Robyn Guymer, AM, MBBS, PhD

The Science Behind Advanced Surgical 3D Imaging

David R. Chow, MD, Timothy G. Murray, MD, MBA

Discussing AMD and Treatment Options with Patients

David Lubeck, MD, David R. Chow, MD, Frank Holz, MD, Netan Choudhry, MD, FRCS(C), Rishi Singh, MD, Robyn Guymer, AM, MBBS, PhD

The LEAD Study and Application of Ellex 2RT

David Lubeck, MD, David R. Chow, MD, Frank Holz, MD, Netan Choudhry, MD, FRCS(C, Rishi Singh, MD, Robyn Guymer, AM, MBBS, PhD

Transitioning from Monitoring to Treating AMD

David Lubeck, MD, David R. Chow, MD, Frank Holz, MD, Netan Choudhry, MD, FRCS(C), Rishi Singh, MD, Robyn Guymer, AM, MBBS, PhD

A Closer Look at 8 mg Aflibercept

David R. Chow, MD, FRCS(C)